0001209191-16-092938.txt : 20160121
0001209191-16-092938.hdr.sgml : 20160121
20160121174508
ACCESSION NUMBER: 0001209191-16-092938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160119
FILED AS OF DATE: 20160121
DATE AS OF CHANGE: 20160121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Machado Clarence Patrick
CENTRAL INDEX KEY: 0001311210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 161354318
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-19
0
0001011835
MEDIVATION, INC.
MDVN
0001311210
Machado Clarence Patrick
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2016-01-19
4
M
0
75000
3.367
A
141156
D
Common Stock
2016-01-19
4
S
0
37021
36.62
D
104135
D
Common Stock
2016-01-19
4
S
0
23087
37.50
D
81048
D
Common Stock
2016-01-19
4
S
0
7942
38.62
D
73106
D
Common Stock
2016-01-19
4
S
0
6950
39.19
D
66156
D
Stock Option (Right to Buy)
3.3675
2016-01-19
4
M
0
75000
0.00
D
2020-12-15
Common Stock
75000
33336
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices between $36.06 and $36.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $37.00 and $37.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $38.03 and $38.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $39.00 and $39.56. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Rick Bierly, Attorney-in-fact
2016-01-20